Home

Chronische myeloische Leukämie / Chronic myelogenous leukemia

5.2.2009

http://idw-online.de/pages/de/news299462
Leukämie: Suche nach molekular-gezielten Therapieansätzen
Leukämie, PIM Proteinkinasen, PIM1, PIM2, chronisch myeloische Leukämie (CML), RNA-Interferenz, ABL

22.10.2006

http://www.uni-protokolle.de/nachrichten/id/125677/
Von wo aus agieren Tyrosinkinasen?
Tyrosinkinase Leukämie Zentrosom, Chronische Myeloische Leukämie, CML

13.12.2010

http://www.eurekalert.org/pub_releases/2010-12/joci-nan120910.php
New approaches needed for treating chronic myeloid leukemia
Chronic myeloid leukemia (CML), BCR-ABL

2.8.2008

http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0002594
Human AQP5 Plays a Role in the Progression of Chronic Myelogenous Leukemia (CML)

17.6.2007

http://www.eurekalert.org/pub_releases/2007-06/ka-cap060807.php
ChemGenex announces publication confirming activity of Ceflatonin in T315I-Positive CML
chronic myeloid leukemia (CML), T315I Bcr-Abl mutation, Ceflatonin (homoharringtonine, HHT), Ceflatonin (homoharringtonine, HHT) Gleevec-resistant, CML, T315I Bcr-Abl mutation

31.1.2011

http://www.physorg.com/news/2011-01-southampton-scientists-patient-trials-leukemia.html
Southampton scientists begin patient trials of new leukemia cancer vaccine
DNA-vaccine, BCR-ABL, chronic myeloid leukaemia, AML, tyrosine kinase inhibitors

6.5.2007

http://www.eurekalert.org/pub_releases/2007-05/jotn-ls042607.php
Unstable leukemia stem cells may predispose patients to drug resistance
BCR-ABL gene, chronic myeloid leukemia stem cells

7.10.2008

http://www.jci.org/articles/view/33337
Ablation of PI3K blocks BCR-ABL leukemogenesis in mice, and a dual PI3K/mTOR inhibitor prevents expansion of human BCR-ABL+ leukemia cells
mTOR, chronic myelogenous leukemia

13.12.2007

http://www.eurekalert.org/pub_releases/2007-12/ohs-oci120707.php
OHSU Cancer Institute research discovery opens new window to understanding chronic myeloid leukemia
chromosome-7, duplication-of-chromosome-8

3.1.2008

http://www.sciencedaily.com/releases/2007/12/071210163311.htm
New Drug Candidate Knocks Out Resistant Form Of Chronic Myeloid Leukemia
T315I SGX393

28.9.2006

http://www.eurekalert.org/pub_releases/2006-09/si-dff090706.php
Distinguishing friend from foe in the battle against cancer
oncoproteins rapamycin, chronic myelogenous leukemia, NF-kB

30.3.2011

http://hematology.org/News/2011/6545.aspx
Study Reveals No Impact of Age on Outcome in Chronic Myeloid Leukemia Patients Treated With Imatinib

6.8.2009

http://www.eurekalert.org/pub_releases/2009-08/uomh-fkt080409.php
Finding key to cancer drug Gleevec's limitations
chronic myeloid leukemia

10.12.2006

http://www.eurekalert.org/pub_releases/2006-12/hhmi-fss120506.php
5-year study shows Gleevec's potency against chronic myeloid leukemia
Gleevec

13.12.2007

http://www.newswise.com/articles/view/536055
Dasatinib and Nilotinib Show Strong Early Results as Frontline Therapy for Chronic Myelogenous Leukemia

13.12.2007

http://www.eurekalert.org/pub_releases/2007-12/uotm-dns120707.php
Dasatinib, Nilotinib show strong early results as frontline therapy for chronic myelogenous leukemia

8.6.2007

http://www.eurekalert.org/pub_releases/2007-06/uotm-dsh060107.php
Dasatinib shows high early response rate as first treatment for chronic myelogenous leukemia

21.12.2007

http://www.aerzteblatt.de/v4/news/news.asp?id=30807
Medizin: Patienten mit chronisch-myeloischer Leukämie sprechen auf Tyrosinkinasinhibitor an
(CML) Tyrosinkinase-Inhibitor Imatinib (Glivec)

18.8.2004

http://www.welt.de/data/2004/08/12/317888.html
Leukämie-Protein entdeckt
Leukämie Protein entdecken, CML, Oberflächenstrukturen, Krebsstammzellen

28.2.2005

http://www.eurekalert.org/pub_releases/2005-02/uorm-pda022205.php
Plant derivative attacks the roots of leukemia
Leukämie bekämpfen, Gänseblümchen Daisy, COX-2-Hemmer Parthenolid, Feverfew, AML, CML

14.7.2010

http://www.eurekalert.org/pub_releases/2010-07/wifb-ptp070710.php
Protein that predicts prognosis of leukemia patients may also be a therapeutic target
Musashi-2 Musashi 2 CML, AML

5.3.2010

http://www.eurekalert.org/pub_releases/2010-03/osum-sik030410.php
Study identifies key cause of chronic leukemia progression
miR-328, imatinib Gleevec, dasatinib Sprycel, CML

6.3.2010

http://www.eurekalert.org/pub_releases/2010-03/osum-sik030410.php
Study identifies key cause of chronic leukemia progression
leukemia-progression miR-328, CML

24.5.2011

http://www.eurekalert.org/pub_releases/2011-05/nyph-wcd052411.php
Weill Cornell drug stops aggressive form of childhood leukemia
childhood-leukemia, acute lymphoblastic leukemia, Philadelphia chromosome, CML, Gleevec, BCL6

25.5.2011

http://www.eurekalert.org/pub_releases/2011-05/nyph-wcd052411.php
Weill Cornell drug stops aggressive form of childhood leukemia
BCL6 Ph+ A-L-L, Gleevec CML

14.6.2011

http://medicalxpress.com/news/2011-06-efficient-therapy-specific-leukemia.html
Toward a more efficient therapy for a specific form of leukemia
imatinib, CML, placental growth factor (PlGF), BCR-ABL1 fusion kinase, antibodies against PlGF (antiPlGF)

14.6.2011

http://www.eurekalert.org/pub_releases/2011-06/vfi-tam061411.php
Toward a more efficient therapy for a specific form of leukemia
imatinib, CML, placental growth factor (PlGF), BCR-ABL1 fusion kinase, antibodies against PlGF (antiPlGF)

1.5.2008

http://sciencenow.sciencemag.org/cgi/content/full/2008/414/4?rss=1
Mutation May Explain Deadly Form of Leukemia
acute lymphoblastic leukemia, ikaros gene, Philadelphia chromosome, CML

25.5.2011

http://medicalxpress.com/news/2011-05-drug-aggressive-childhood-leukemia.html
New drug stops aggressive form of childhood leukemia
aggressive-form-of-childhood-leukemia New-drug-stops-leukemia, CML, BCL6, Ph+

7.1.2010

http://www.eurekalert.org/pub_releases/2010-01/jhmi-jhr010610.php
Johns Hopkins researchers say vaccine appears to 'mop up' leukemia cells Gleevec leaves behind
Imatinib mesylate (Gleevec), CML, GM-CSF, dasatinib, nilotinib

11.4.2008

http://www.hhmi.org/news/gilliland20080407.html
New Drug Targets Three Kinds of Leukemia
JAK2 gene, JAK2-mutation, Gleevec, CML, TG101348, tyrosine kinases, Gary Gilliland

31.8.2007

http://www.eurekalert.org/pub_releases/2007-08/osu-nmd082807.php
Novel MS drug shows promise in 2 lethal leukemias
Multiple-Sklerose imatinib dasatinib fingolimod PP2A CML A-L-L

3.3.2010

http://www.eurekalert.org/pub_releases/2010-03/w-tlc030310.php
Targeting leukemia cell's gene 'addiction' presents new strategy for treatment
Stat5 Stat3 Bcr/Abl-induced leukaemia growth, CML, A-L-L, Imatinib, Non-oncogene addiction' (NOA)

25.3.2008

http://www.eurekalert.org/pub_releases/2008-03/ohs-oci032408.php
OHSU Cancer Institute researchers identify new approach to help control drug resistance in leukemia
SGX393 CML

3.1.2008

http://www.sciencedaily.com/releases/2007/12/071210094430.htm
Scientists Discover New Role For MiRNA In Leukemia
CML miR-328 Gleevec, dasatinib Sprycel

12.4.2011

http://www.physorg.com/news/2011-04-drug-potential-treatment-resistant-leukemia.html
New drug shows potential for treatment-resistant leukemia
DCC-2036, CML, BCR-ABL1

26.3.2008

http://www.sciencedaily.com/releases/2008/03/080324173534.htm
New Approach To Help Control Drug Resistance In Leukemia Identified
Gleevec SGX393 CML

22.6.2008

http://www.eurekalert.org/pub_releases/2008-06/uom-mch061908.php
Math could help cure leukemia
Best Time for Immune Response, CML, imatinib

13.12.2007

http://www.biologynews.net/archives/2007/12/09/scientists_discover_new_role_for_mirna_in_leukemia.html
Scientists discover new role for miRNA in leukemia
CML imatinib (Gleevec) and dasatinib (Sprycel), miR-328

24.5.2008

http://scienceblog.com/16340/arsenic-based-therapy-helps-eradicate-leukemia-initiating-cells/
Arsenic-Based Therapy Helps Eradicate Leukemia Initiating Cells
leukemia initiating cells LICs, PML CML Gleevec

13.12.2007

http://www.innovations-report.de/html/berichte/biowissenschaften_chemie/bericht-99842.html
Scientists discover new role for miRNA in leukemia
CML, miR-328

31.5.2010

http://www.eurekalert.org/pub_releases/2010-05/cp-ctt051010.php
Combination therapy targets stubborn leukemia stem cells
stubborn BCR-ABL oncoprotein, CML

4.10.2009

http://www.biomedcentral.com/1755-8794/2/20
The apoptotic machinery as a biological complex system: analysis of its omics and evolution, identification of candidate genes for fourteen major types of cancer and experimental validation in CML and neuroblastoma
LIVER CML 2 CANCER

13.12.2007

http://www.brightsurf.com/news/headlines/34755/Early_Phase_II_results_show_bosutinib_safe_effective_for_CML.html
Early Phase II results show bosutinib safe, effective for CML
bosutinib